Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials

Documenti analoghi

• Erratum to: Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials
  di: Adsit, Sandra, et al.
  Pubblicazione: (2017)
• Efficacy of Secukinumab on Moderate-to-severe Plaque Psoriasis Affecting Different Body Regions: a Pooled Analysis of Four Phase 3 Studies
  di: Menter, Alan, et al.
  Pubblicazione: (2016)
• Efficacy of Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis in the North American Subgroup of Patients: Pooled Analysis of Four Phase 3 Studies
  di: Pariser, David, et al.
  Pubblicazione: (2017)
• Efficacy of Secukinumab for Moderate-to-Severe Head and Neck Psoriasis Over 52 Weeks: Pooled Analysis of Four Phase 3 Studies
  di: Kircik, Leon, et al.
  Pubblicazione: (2016)
• Secukinumab in the Treatment of Plaque Psoriasis in Patients with Malignancy
  di: Alessio Gambardella
  Pubblicazione: (2019-09-01)